These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34307909)

  • 21. Effects of particulate matter exposure on the expression of the SARS-CoV-2 ACE2 receptor in ocular surface tissues and cells.
    Li X; Li X; Kang B; Eom Y; Lee HK; Kim DH; Zhong J; Song JS
    Environ Sci Pollut Res Int; 2024 Feb; 31(6):8768-8780. PubMed ID: 38180673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repurposing Niclosamide as a Novel Anti-SARS-CoV-2 Drug by Restricting Entry Protein CD147.
    Yang Z; Zhang Q; Wu X; Hao S; Hao X; Jones E; Zhang Y; Qiu J; Xu L
    Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human eggs, zygotes, and embryos express the receptor angiotensin 1-converting enzyme 2 and transmembrane serine protease 2 protein necessary for severe acute respiratory syndrome coronavirus 2 infection.
    Rajput SK; Logsdon DM; Kile B; Engelhorn HJ; Goheen B; Khan S; Swain J; McCormick S; Schoolcraft WB; Yuan Y; Krisher RL
    F S Sci; 2021 Feb; 2(1):33-42. PubMed ID: 33521687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Host-Cell Surface Binding Targets in SARS-CoV-2 for Drug Design.
    Maleksabet H; Rezaee E; Tabatabai SA
    Curr Pharm Des; 2022; 28(45):3583-3591. PubMed ID: 36420875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2 cell entry beyond the ACE2 receptor.
    Alipoor SD; Mirsaeidi M
    Mol Biol Rep; 2022 Nov; 49(11):10715-10727. PubMed ID: 35754059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repurposing niclosamide as a novel anti-SARS-Cov-2 drug by restricting entry protein CD147.
    Yang Z; Zhang Q; Wu X; Hao S; Hao X; Jones E; Zhang Y; Qiu J; Xu L
    Res Sq; 2023 Apr; ():. PubMed ID: 37090542
    [No Abstract]   [Full Text] [Related]  

  • 27. ACE2-Independent Alternative Receptors for SARS-CoV-2.
    Lim S; Zhang M; Chang TL
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36423144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk Factors.
    Wicik Z; Eyileten C; Jakubik D; Simões SN; Martins DC; Pavão R; Siller-Matula JM; Postula M
    J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33233425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced susceptibility of SARS-CoV-2 spike RBD protein assay targeted by cellular receptors ACE2 and CD147: Multivariate data analysis of multisine impedimetric response.
    Brodowski M; Pierpaoli M; Janik M; Kowalski M; Ficek M; Slepski P; Trzaskowski B; Swain G; Ryl J; Bogdanowicz R
    Sens Actuators B Chem; 2022 Nov; 370():132427. PubMed ID: 35911567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities.
    Zamorano Cuervo N; Grandvaux N
    Elife; 2020 Nov; 9():. PubMed ID: 33164751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a Novel Human CD147 Transgenic NSG Mouse Model to test SARS-CoV-2 Infection and Immune Responses.
    Badeti S; Tseng HC; Romanienko P; Yehia G; Liu D
    Res Sq; 2021 Apr; ():. PubMed ID: 33851148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relevance of VEGF and CD147 in different SARS-CoV-2 positive digestive tracts characterized by thrombotic damage.
    Bortolotti D; Simioni C; Neri LM; Rizzo R; Semprini CM; Occhionorelli S; Laface I; Sanz JM; Schiuma G; Rizzo S; Varano G; Beltrami S; Gentili V; Gafà R; Passaro A
    FASEB J; 2021 Dec; 35(12):e21969. PubMed ID: 34822202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Going viral in the islet: mediators of SARS-CoV-2 entry beyond ACE2.
    Rangu R; Wander PL; Barrow BM; Zraika S
    J Mol Endocrinol; 2022 Jun; 69(2):R63-R79. PubMed ID: 35521990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Susceptibility of neuroblastoma and glioblastoma cell lines to SARS-CoV-2 infection.
    Bielarz V; Willemart K; Avalosse N; De Swert K; Lotfi R; Lejeune N; Poulain F; Ninanne N; Gilloteaux J; Gillet N; Nicaise C
    Brain Res; 2021 May; 1758():147344. PubMed ID: 33556379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-CoV-2 infection and replication kinetics in different human cell types: The role of autophagy, cellular metabolism and ACE2 expression.
    Bartolomeo CS; Lemes RMR; Morais RL; Pereria GC; Nunes TA; Costa AJ; de Barros Maciel RM; Braconi CT; Maricato JT; Janini LMR; Okuda LH; Lee KS; Prado CM; Ureshino RP; Stilhano RS
    Life Sci; 2022 Nov; 308():120930. PubMed ID: 36075471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?
    Gemmati D; Bramanti B; Serino ML; Secchiero P; Zauli G; Tisato V
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32423094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of SARS-CoV-2 entry in gingival epithelial cells expressing CD147.
    Bontempo A; Chirino A; Heidari A; Boparai S; Arora S; Ruiz S; Antonson SA; Kawai T; Cayabyab MJ
    Eur J Oral Sci; 2023 Feb; 131(1):e12906. PubMed ID: 36412995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integration of clinical characteristics and molecular signatures of the tumor microenvironment to predict the prognosis of neuroblastoma.
    Cheng H; Zhang L; Yang S; Ren Q; Chang S; Jin Y; Mou W; Qin H; Yang W; Zhang X; Zhang W; Wang H
    J Mol Med (Berl); 2023 Nov; 101(11):1421-1436. PubMed ID: 37712965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systems level insights into the impact of airborne exposure on SARS-CoV-2 pathogenesis and COVID-19 outcome - A multi-omics big data study.
    Manivannan J; Sundaresan L
    Gene Rep; 2021 Dec; 25():101312. PubMed ID: 34401607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19, Cation Dysmetabolism, Sialic Acid, CD147, ACE2, Viroporins, Hepcidin and Ferroptosis: A Possible Unifying Hypothesis.
    Cavezzi A; Menicagli R; Troiani E; Corrao S
    F1000Res; 2022; 11():102. PubMed ID: 35340277
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.